A carregar...
Phase I/II study of S-1 combined with irinotecan for metastatic advanced gastric cancer
A dose-escalation study of irinotecan (CPT-11) combined with S-1, an oral dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine, was performed to determine the maximum-tolerated dose (MTD), recommended dose (RD), dose-limiting toxicities (DLTs), and objective response rate (RR) in advanced gas...
Na minha lista:
| Main Authors: | , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Publishing Group
2006
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2361252/ https://ncbi.nlm.nih.gov/pubmed/16570038 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6603072 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|